10.9DKK
3.02 BDKK
17.90 BDKK
349.68 M
About NOVONESIS (NOVOZYMES) B SER'B'DKK2
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
Employees (FY)
6.76 K
ISIN
DK0060336014
FIGI
BBG000P9CV00
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0Q4U is 386.3 DKK — it has increased by 0.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange NOVONESIS (NOVOZYMES) B SER'B'DKK2 stocks are traded under the ticker 0Q4U.
NOVONESIS (NOVOZYMES) B SER'B'DKK2 is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
0Q4U stock is 1.13% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is NOVONESIS (NOVOZYMES) B SER'B'DKK2 there?
0Q4U earnings for the last quarter are 3.37 DKK per share, whereas the estimation was 2.88 DKK resulting in a 16.84% surprise. The estimated earnings for the next quarter are 3.20 DKK per share. See more details about NOVONESIS (NOVOZYMES) B SER'B'DKK2 earnings.
NOVONESIS (NOVOZYMES) B SER'B'DKK2 revenue for the last quarter amounts to 4.46 B DKK despite the estimated figure of 4.41 B DKK. In the next quarter revenue is expected to reach 4.62 B DKK.
Yes, you can track NOVONESIS (NOVOZYMES) B SER'B'DKK2 financials in yearly and quarterly reports right on TradingView.
0Q4U stock has risen by 0.13% compared to the previous week, the month change is a 4.66% fall, over the last year NOVONESIS (NOVOZYMES) B SER'B'DKK2 has showed a 10.14% increase.
0Q4U net income for the last quarter is 698.00 M DKK, while the quarter before that showed 936.00 M DKK of net income which accounts for −25.43% change. Track more NOVONESIS (NOVOZYMES) B SER'B'DKK2 financial stats to get the full picture.
Today NOVONESIS (NOVOZYMES) B SER'B'DKK2 has the market capitalization of 178.74 B, it has increased by 0.65% over the last week.
NOVONESIS (NOVOZYMES) B SER'B'DKK2 dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0Q4U shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS (NOVOZYMES) B SER'B'DKK2 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS (NOVOZYMES) B SER'B'DKK2 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS (NOVOZYMES) B SER'B'DKK2 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS (NOVOZYMES) B SER'B'DKK2 stock shows the buy signal. See more of NOVONESIS (NOVOZYMES) B SER'B'DKK2 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVONESIS (NOVOZYMES) B SER'B'DKK2 future price: according to them, 0Q4U price has a max estimate of 475.00 DKK and a min estimate of 350.00 DKK. Read a more detailed NOVONESIS (NOVOZYMES) B SER'B'DKK2 forecast: see what analysts think of NOVONESIS (NOVOZYMES) B SER'B'DKK2 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS (NOVOZYMES) B SER'B'DKK2 EBITDA is 5.83 B DKK, and current EBITDA margin is 32.72%. See more stats in NOVONESIS (NOVOZYMES) B SER'B'DKK2 financial statements.